AN2 Therapeutics, Inc.'s total assets for Q3 2025 were $67.23M, a decrease of -11.33% from the previous quarter. ANTX total liabilities were $6.86M for the fiscal quarter, a -1.79% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.